BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Polysaccharides from <i>Chrysanthemum morifolium</i> Ramat ameliorate colitis rats by modulating the intestinal microbiota community. ✅
Go to Publication ✅
Oncotarget (Oncotarget ) Vol: 8 Issue 46 Pages: 80790-80803 Pub: 2017 Oct 6 Epub: 2017 Aug 24 Authors Tao JH , Duan JA , Jiang S , Feng NN , Qiu WQ , Ling Y , |
|
|
Chrysanthemum morifolium attenuates metabolic and alcohol-associated liver disease via gut microbiota and PPARa/? activation. ✅
Go to Publication ✅
Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine ) Vol: 130 Issue Pages: 155774 Pub: 2024 Jul 25 Epub: 2024 May 23 Authors Liu D , Zhan J , Wang S , Chen L , Zhu Q , Nie R , Zhou X , Zheng W , Luo X , Wang B , Nie J , Ye X , |
|
|
Tea extracts modulate oral biofilm development by altering bacterial hydrophobicity and aggregation. ✅
Go to Publication ✅
Archives of oral biology (Arch Oral Biol ) Vol: 122 Issue Pages: 105032 Pub: 2021 Feb Epub: 2020 Dec 27 Authors Wang Y , Samaranayake LP , Dykes GA , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
